September 26, 2025
Recce Pharmaceuticals (ASX:RCE) moves into Phase 3 with Indonesian diabetic foot infection trial
Recce Pharmaceuticals (ASX:RCE) has commenced patient dosing in its registrational Phase 3 trial for diabetic foot infections in Indonesia, one of the largest such studies globally.